Committee for Orphan Medical Products invitation to myeloma patients

The European Medicines Agency is currently inviting one or two myeloma patients to participate in a discussion and oral explanation about a potential medicine to treat the disease during the COMP meeting in January (Committee for Orphan Medical Products). The discussions relates to an orphan designation for a potential drug to treat multiple myeloma and the patients designated will be able to contribute from a patient perspective.

Creating your Business Plan Workshop

Where is your patient group? Where do you want to get to? How you will get there? Patient organisations usually find several issues when trying to achieve their objectives due to limitations in terms of resources, time or strategy. However, some other are able so overcome these barriers and succeed in their mission. So how are they able to make it? The answer is simple: they have a plan.

MPE to be present at the 56th ASH Annual Meeting

Myeloma Patients Europe will be present at the 56th American Society of Hematology Annual Meeting, to be held in San Francisco betweeb 6 and 9 December. Over 20.000 people from all arround the globe will attend the largest hematology event in the world. Hundreds of sessions, posters and exhibits will bring together, not only hematologists, but also other stakeholders, such as non-clinical researchers, nurses, industry and, of course, patients.